Skip to Content
GenesGenes
  • Review
  • Open Access

21 November 2025

40 Pages

A Single-Cell Omics Technical Guide for Advancing Neuropsychiatric Research

,
,
,
and
1
McGill Group for Suicide Studies, Douglas Mental Health University Institute, Montreal, QC H4H 1R3, Canada
2
Integrated Program in Neuroscience, McGill University, Montreal, QC H3A 1A1, Canada
3
Department of Human Genetics, McGill University, Montreal, QC H3A 1Y2, Canada
4
Department of Psychiatry, McGill University, Montreal, QC H3A 1A1, Canada

Abstract

Single-cell omics technology has advanced rapidly since its inception, offering increasing precision, resolution, and technical diversity to explore cell-specific molecular features in the human brain and neuropsychiatric disorders. While traditional bulk genomic analyses have provided valuable insights into the molecular processes of these disorders, single-cell omics allows for the investigation of cellular heterogeneity in the brain, which is crucial for dissecting underlying pathology. Neuropsychiatric disorders—such as dementia and depression—are complex and heterogenous brain disorders driven by intricate interactions of genetic and environmental factors. Methodological developments in single-cell omic technologies have enabled their application directly to human brain tissue for the study of neuropsychiatric disorders, yielding cell-specific insights in transcriptomics and epigenomics, with emerging findings in proteomics, metabolomics, multi-omics, and beyond. This review discusses different single-cell omic technologies, focusing on their application to postmortem human brain tissue, highlighting key findings from the use of these methods in neuropsychiatric disorders, and providing considerations for future implementation to elucidate the molecular landscape of brain changes associated with these conditions.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.